Condition: Septic Shock · Hypoperfusion · Sponsor: Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva
The aim of the study is to evaluate the viability and feasibility of its protocol in order to conduct a larger clinical trial to assess whether methylene blue can improve patient-centered clinical outcomes such as mortality or length of hospital stay in septic shock patients.
This description comes directly from the study's public registry record.
Bruna Dal Vesco · +55 (41) 3362-6633 · brunadalvesco@gmail.com
Always discuss trial participation with your own doctor first.
| Irmandade da Santa Casa de Misericórdia de Curitiba | Curitiba, Paraná, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07264543